Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A prospective double-blinded comparative analysis of framycetin and silver sulphadiazine as topical agents for burns: A pilot study
Burns, 07/02/09
Ahuja RB et al. - According to this pilot study results framycetin appears to be an alternative to silver suphadiazine as a topical agent for major burns. Framycetin application is also painless and it leads to no discoloration of the wound.
Related Articles
Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar
Burns, 11/13/09
Relevance Score: 93%
Early management of burns in children
Paediatrics and Child Health, 11/11/09
Relevance Score: 93%
Is superficial burn caused by ultraviolet radiation (sunburn) comparable to superficial burn caused by heat a histomorphological comparison by in vivo Reflectance-Mode-Confocal Microscopy
Journal of the European Academy of Dermatology and Venereology, 11/18/09
Relevance Score: 92%
The Nitric acid burn trauma of the skin
Journal of Plastic, Reconstructive & Aesthetic Surgery, 11/10/09
Relevance Score: 91%
Evaluation of mortality following severe burns injury in Hungary: External validation of a prediction model developed on Belgian burn data
Burns, 10/01/09
Relevance Score: 91%
Today in Emergency/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Convulsive and non-convulsive status epilepticus: An emergency medicine perspective
Emergency Medicine Australasia, 12/10/09
Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09
Adverse outcomes following emergency department discharge of patients with possible acute coronary syndrome
Emergency Medicine Australasia, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


